Smartlab Europe

Columbia Asia performs its first stem cell transplant

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

CMS Extends GENEROUS MFN Drug Pricing Deadline to April

The Centers for Medicare & Medicaid Services (CMS) in...

Lilly Launches New AI Supercomputer for Drug Development

Eli Lilly has launched what it describes as the...

Periodontal Disease as a Modifiable Risk Factor in Systemic Conditions

Periodontal disease has long been viewed primarily as a...
- Advertisement -

Columbia Asia Hospital – Yeshwanthpur in Bangalore performed its first stem cell transplant recently. The Times of India featured the procedure this week and described how a 44-year-old Swiss man was unable to walk without help until he came to Columbia Asia.
Clinical haematologist Dr Sathish Kumar and medical oncologist Dr Neelesh Reddy of Columbia Asia gave Daniel four cycles of chemotherapy, including a high-dose treatment. This was followed by autologous stem cell transplantation.

In autologous transplant, stem cells are used from the patient’s body. These cells are removed from the body before the chemotherapy and transplanted after the treatment is over. The transplant not only improved Daniel’s quality of life but also prolonged his survival. According to the doctors, Daniel is now symptom-free and leads a healthy, productive life.

Dr Sathish said, Stem cell transplant is not new. However, now it’s becoming more accessible. This was our first stem cell transplant. Daniel works in Bangalore and had planned to go back to Switzerland for the stem cell transplant, but today he has confidence in the healthcare available here.

Latest stories

Related stories

CMS Extends GENEROUS MFN Drug Pricing Deadline to April

The Centers for Medicare & Medicaid Services (CMS) in...

Lilly Launches New AI Supercomputer for Drug Development

Eli Lilly has launched what it describes as the...

Periodontal Disease as a Modifiable Risk Factor in Systemic Conditions

Periodontal disease has long been viewed primarily as a...

How Pharma is Navigating EPR’s Split-Tier Reality in 2026 without Losing Regulatory Sterility

In 2026, the Pharmaceutical and Medical Device sectors face...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »